No Data
Guangdong Silver Age Sci&Tech,Co.,Ltd. (300221.SZ): The carbon fiber materials and composites produced by the company can be applied in new energy battery housings, drones, etc.
Gelonghui, November 15 - Guangdong Silver Age Sci&Tech, Co., Ltd. (300221.SZ) stated on the investor interaction platform that the company produces carbon fiber composite materials, which can be used in new energy battery casings, drones, and other applications. The revenue from this product has not reached the disclosure standard in the company's consolidated financial statements.
Guangdong Silver Age Sci&Tech,Co.,Ltd. (300221.SZ): Currently not providing products to Hytera Communications Corporation.
Glory11 reports on November 7th that Guangdong Silver Age Sci&Tech,Co.,Ltd.(300221.SZ) stated on the investor interaction platform that the company's polymer material products are widely used in household appliances, electrical wires and cables, modern agriculture, rail transportation, aviation and aerospace, high-end equipment, communications, electronics, electrical, building decoration, new energy vehicle and other industries. The company currently does not provide products to Hytera Communications Corporation, and is also unaware of whether downstream customers have any business with it.
Jubilee Technology: Q3 2024 Report
guangdong silver age sci&tech,co.,ltd. (300221.SZ) releases its performance for the first three quarters, with a net income of 39.1485 million yuan, a 46.66% increase.
guangdong silver age sci&tech,co.,ltd. (300221.SZ) released the third quarter report of 2024, with revenue in the first three quarters reaching 1...
Express News | Today, 14 listed companies' stocks were repurchased, with the highest repurchase amount in Quzhou Development.
Guangdong Silver Age Sci&Tech,Co.,Ltd. (300221.SZ): Beta-nicotinamide mononucleotide related products are not the strategic direction of HingBio.
Guangdong Silver Age Sci&Tech,Co.,Ltd. (300221.SZ) stated on the investor interaction platform on September 11 that the company's subsidiary, Dongguan Jinghang New Materials Investment Partnership Enterprise (Limited Partnership), has invested in Suzhou Yinhang Biotechnology Co., Ltd. The company is mainly engaged in the research and development, production, and sales of industrial biotechnology and products in the fields of pharmaceuticals and health, animal nutrition, animal health, and plant protection. β-Nicotinamide mononucleotide-related products are not the strategic direction of Yinhang Biology, and there has been no progress in the research and development of related products.
No Data
No Data